About Us

  About NRC

The National Research Centre (NRC) is the largest multidisciplinary R&D centre in Egypt devoted to basic and applied research within the major fields of interest. It was established as an independent public organization in 1956 "to foster basic and applied scientific research. It is affiliated with the ministry of Scientific Research. The NRC has to correspond to the country's key production and services sectors through the research conducted in different areas of science and technology, scientific consultation and training as well.
NRC possesses an impressive scientific and technological infrastructure and man power resources of 4847 research staff. It consists of 14 divisions and 108 departments covering the major areas of industry, pharmacy, health, environment, agriculture, basic sciences engineering and genetics.

  About Pharmaceutical and Drug Industries Research Division

The Pharmaceutical Industries Research Division is the house of experience and the bank for scientific consultation for the development of scientific pharmaceutical research. The Pharmaceutical and Drug Industries Research Division is in close relation to the pharmaceutical industries and various industrial companies through applied research under the umbrella of ethics and values of scientific research to serve and develop the national economy. The total number of employees in the division (members of the research authority and their assistants) are 511 members. The Pharmaceutical and Drug Industries Research Division includes nine departments, which cover several fields such as: (1) biochemistry, immunology and omicstechnology, (2) molecular genetics and therapeutic approaches (DNA and Gene Therapy), (3) microbiology, fermentation biotechnology and molecular biology, (4) nanobiotechnology, (5) recent advances in drug delivery systems, (6) new trends in natural and microbial products, (7) chirality and drug design, (8) pharmacological and toxicological evaluation of natural and synthetic leads, (9) evaluation, conservation and sustainable use of medicinal and aromatic plants, (10) green technology in pharmaceutical industries, (11) pharmacognosy, (12) pharmaceutical technology and chemical synthesis of biopharmaceutics, (13) chemistry and biology of plant constituents. Also, the Pharmaceutical and Drug Industries Research Division organized five international conferences from 2003 -2015 in the field of applied research for drug industry and advances in pharmaceutical research. In addition, the 6th International Conference will be held in 2017 (October 23-24) covering several new trends in pharmaceutical research that facilitate scientific international collaboration.

  About the Journal

Egyptian Pharmaceutical Journal, a publication of Division of Pharmaceutical and Drug Industries Research, National Research Centre, is a peer-reviewed online journal with 3 issues print on demand compilation of issues published. The journal’s full text is available online at http://www.epj.eg.net. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository. The journal does not charge for submission, processing or publication of manuscripts and even for color reproduction of photographs.

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Exlibris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet

Journal Ethics

Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp

Open Access Publication and Creative Commons Licensing

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Digital Archiving

Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.

Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.

CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.

Ahead of Print policy

Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.

Advertisements

While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:

  • "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
  • The Editorial Board has full and final approval over the content of all advertisements.
  • Advertisers will never be shown any manuscripts or other content prior to publication.

  Scope of the journal

The journal will cover technical and clinical studies related to health, ethical and social issues in field of Pharmacy. Articles with clinical interest and implications will be given preference.

    Medknow Publications   Top
Feedback
Editorial board
Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal